Lineage Cell Therapeutics
LCTX
#8743
Rank
A$0.19 B
Marketcap
$0.86
Share price
-1.91%
Change (1 day)
-47.55%
Change (1 year)

Lineage Cell Therapeutics (LCTX) - Cash on Hand

Cash on Hand as of September 2024 : A$52.45 Million

According to Lineage Cell Therapeutics 's latest financial reports the company has A$52.45 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Lineage Cell Therapeutics - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$52.09 M-38.75%
2022-12-31A$85.04 M5.65%
2021-12-31A$80.49 M48.92%
2020-12-31A$54.05 M23.21%
2019-12-31A$43.87 M0.54%
2018-12-31A$43.63 M-10.76%
2017-12-31A$48.89 M55.17%
2016-12-31A$31.51 M-46.59%
2015-12-31A$59 M63.74%
2014-12-31A$36.03 M484.87%
2013-12-31A$6.16 M47.18%
2012-12-31A$4.18 M-80.68%
2011-12-31A$21.66 M-33.97%
2010-12-31A$32.8 M141.78%
2009-12-31A$13.56 M77863.03%
2008-12-31A$0.01 M60.15%
2007-12-31A$0.01 M-98.47%
2006-12-31A$0.71 M-71.6%
2005-12-31A$2.5 M41.48%
2004-12-31A$1.77 M83.59%
2003-12-31A$0.96 M-57.68%
2002-12-31A$2.27 M-29.6%
2001-12-31A$3.23 M37.34%
2000-12-31A$2.35 M-70.73%
1999-12-31A$8.05 M105.49%
1998-12-31A$3.91 M
1998-06-30A$6.6 M-36.07%
1997-06-30A$10.33 M238.86%
1996-06-30A$3.04 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$0.43 B 732.65%๐Ÿ‡บ๐Ÿ‡ธ USA